Does gonadotropin-releasing hormone agonist therapy affect bone mineral density in congenital adrenal hyperplasia: A Longitudinal study

被引：0
|
作者：
Flokas, Myrto [1 ,2 ]
Kollender, Sarah [3 ]
Parker, Megan [3 ]
Mallappa, Ashwini [3 ]
Merke, Deborah [3 ,4 ]
机构：
[1] Childrens Natl Hosp, Washington, DC USA
[2] NICHD, Washington, DC USA
[3] NIH, Ctr Clin, Bethesda, MD 20892 USA
[4] NICHD, Bethesda, MD USA
来源：
HORMONE RESEARCH IN PAEDIATRICS | 2022年 / 95卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5052
引用
收藏
页码：24 / 25
页数：2
相关论文
共 50 条
  • [21] Sertraline in the treatment of depression associated with gonadotropin-releasing hormone agonist therapy
    Warnock, JK
    Bundren, JC
    Morris, DW
    BIOLOGICAL PSYCHIATRY, 1998, 43 (06) : 464 - 465
  • [22] Conservative therapy with a gonadotropin-releasing hormone agonist for a uterine arteriovenous malformation in a patient with congenital heart disease
    Katano, Kinue
    Takeda, Yutaka
    Sugiura-Ogasawara, Mayumi
    CLINICAL CASE REPORTS, 2015, 3 (06): : 479 - 482
  • [23] Gonadotropin-releasing hormone agonist in premenopausal women does not alter hypothalamic-pituitary-adrenal axis response to corticotropin-releasing hormone
    Gavin, Kathleen M.
    Shea, Karen L.
    Gibbons, Ellie
    Wolfe, Pamela
    Schwartz, Robert S.
    Wierman, Margaret E.
    Kohrt, Wendy M.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2018, 315 (02): : E316 - E325
  • [24] FAILURE TO IMPROVE OVARIAN RESPONSE BY COMBINED GONADOTROPIN-RELEASING HORMONE AGONIST AND GONADOTROPIN THERAPY
    BIDER, D
    KOKIA, E
    LIPITZ, S
    BLANKSTEIN, J
    MASHIACH, S
    SERR, DM
    BENRAFAEL, Z
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1990, 29 (03) : 192 - 196
  • [25] Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in Korean girls with central precocious puberty
    Ko, Jung Hee
    Lee, Hyo Sung
    Kim, Shin Mi
    Kim, Eun Young
    Hwang, Jin Soon
    HORMONE RESEARCH, 2009, 72 : 263 - 263
  • [26] Bone mineral density and body composition in girls with idiopathic central precocious puberty before and after treatment with a gonadotropin-releasing hormone agonist
    Alessandri, Sandra B.
    Pereira, Francisco de A.
    Villela, Rosangela A.
    Antonini, Sonir R. R.
    Elias, Paula C. L.
    Martinelli, Carlos E., Jr.
    de Castro, Margaret
    Moreira, Ayrton C.
    de Paula, Francisco J. A.
    CLINICS, 2012, 67 (06) : 591 - 596
  • [27] Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty
    Boot, AM
    Keizer-Schrama, SMPFD
    Pols, HAP
    Krenning, EP
    Drop, SLS
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (02): : 370 - 373
  • [28] The effects of gonadotropin-releasing hormone agonists on bone metabolism markers and bone mineral density in prostate cancer patients
    Miyaji, Y
    Yamamoto, Y
    Tsushima, T
    Kumon, H
    Saika, T
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 1103 - 1107
  • [29] A randomized, placebo-controlled study on the effect of cyclic intermittent etidronate therapy on the bone mineral density changes associated with six months of gonadotropin-releasing hormone agonist treatment
    Mukherjee, T
    Barad, D
    Turk, R
    Freeman, R
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 175 (01) : 105 - 109
  • [30] Height, bone mineral density and bone markers in congenital adrenal hyperplasia
    Paganini, C
    Radetti, G
    Livieri, C
    Braga, V
    Migliavacca, D
    Adami, S
    HORMONE RESEARCH, 2000, 54 (04) : 164 - 168
12345